Neurone Ltd

UK company developing complex botanical pharmaceuticals from extracts of Cannabis Sativa As former members of the GW Pharmaceuticals executive team, where we learned to develop FDA approved medicines from the cannabis plant, we have established Neurone to enable us to pursue the development and approval of the next generation of cannabis based pharmaceuticals. We use complex botanical extracts, obtained from botanical raw material grown in our licensed growing facility, to create novel extract based pharmaceutical products. We will develop IP protected, complex botanical medicines, executing the clinical trials required to secure FDA and other international regulatory approvals in order to enable prescribing and reimbursement needed to achieve broad patient access.